Transactions: Health Industries

Transactions in the healthcare industry have been fuelled in recent years by new technologies, rising pressure on costs and the demand for increased efficiency, as well as the resulting pressure for consolidation. The trend towards focusing on core activities has led to a series of carve-outs. M&A activities are also being driven by social developments including rising life expectancy and mega trends such as digitisation.

On top of this, public and private investors are increasingly keen to invest in robust local health markets. Strategic investors and financial investors see this as a focus point for their long-term growth strategies.

Drive your growth and secure your future

Our Healthcare team offers a full range of services to support you in successfully completing your planned transaction, whether you are a pharmaceutical or life sciences company, a healthcare services provider, a Med-Tech company or one of the new digital players in this market. We’re by your side as a partner with deep industry knowledge and decades of experience in handling high-value M&A activities. For every project, we take advantage of the unique strategic knowledge within the PwC Strategy& team, the local expertise within our Healthcare team, and the power of our international PwC network.

Our expertise:

  • More than 11,000 PwC experts work for the healthcare industry, including 7,000 who are focused on pharma and life sciences, and 4,000 who focus on healthcare services. We have 4,000 experts in North America, 3,500 in Europe and around 2,500 in further regions

  • Financial consulting for 4,185 deals worldwide (with a total value of 460 billion USD) in the last ten years, of which more than 40 percent were international transactions        

  • Healthcare teams in more than 150 countries across 743 branch offices, including regions with innovative clusters and healthcare landscapes

  • Relationships with more than 4,000 healthcare organisations worldwide

An overview of our services

  • Customised transactions consultancy along the entire deal cycle, including pre-deal and exit readiness, M&A, tax structuring, legal and regulatory compliance, valuation, carve-outs, post-deal integration and exit value optimisation
  • Analysing the potential value creation of healthcare deals, spin-offs or divestments

  • Efficient preparations, analysis and processes for conducting the transaction

  • Conducting financial, commercial and operational due diligence, as well as IT, tax and legal due diligence

  • All services from a single source thanks to our interdisciplinary approach

"Transactions: Health Industries" is part of our consulting service. An overview of all our transaction processes you can find here.

Global M&A Trends in Health Industries:
2022 Mid-Year Update

Innovation and attractive growth prospects in health industries create a strong M&A outlook for the remainder of 2022.

Read more

Contact us

Tobias Klimpe

Tobias Klimpe

Partner, Deals: Leader Health Industries, PwC Germany

Follow us